caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1710958509

Jason KonnerMD

PRACTICEMSKCC SURGERY GROUPSee all providers at this practice →
Medical OncologyNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
373
Unique beneficiaries
—
Total services
979
Distinct HCPCS
5
Medicare payment
$92K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 506 Medical Oncology providers in NY — top quintile (cohort median 458).
REFERRAL NETWORK

Where Jason Konner's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 9 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
BELL-MCGUINN, KATHERINE17166
Michelle Johnson
Cardiology · New York, NY
1697
Howard Weinstein
Cardiology · New York, NY
1551
William Tew
Medical Oncology · New York, NY
15131
Dragos Rancea
Internal Medicine · New York, NY
1451
HYMAN, DAVID1374
Jennifer Liu
Cardiology · Manhasset, NY
1368
Scott Gerst
Diagnostic Radiology · New York, NY
1229
Michael Baum
Cardiology · New York, NY
1157
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
600
Beneficiaries
—
Total drug cost
$803K
Distinct drugs
22
Brand share
12.0%
Top prescribed drugs
Dexamethasone76 claims
Lorazepam65 claims
Ondansetron Hcl60 claims
Montelukast Sodium40 claims
Gabapentin35 claims
QUALITY · MIPS · 2024
Final MIPS score
82.8
Quality
80.9
Cost
65.2
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.33%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$3K
Payment records
1
By payment type
Consulting Fee$3K